Understanding the Impact of New Diagnostic Technology in Insurance

Explore the latest advancements in diagnostic technology for predicting and diagnosing cardiac conditions like CHD. Learn about new techniques such as high-tech scanning, biomarker identification, and predictive testing, and understand how these innovations can influence insurance products and risk assessment processes.

• Diagnostic technology
• Cardiac health
• Insurance products
• Risk assessment
• CHD

miby609 Follow

Uploaded on Sep 15, 2024 | 0 Views

Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

Presentation Transcript

1. CHD - the killer questions June 2018 Julie Scott Underwriting Proposition Manager UKLB

2. 1 Introduction FOCUS - CHD killer questions - Julie Scott Underwriting Proposition Manager UKLB 15 September 2024 2

3. What Ill cover this evening 1. 2. 3. 4. What s new in diagnostic technology? What s the impact? How could this affect insurance products? Open the floor for questions FOCUS - CHD killer questions - Julie Scott Underwriting Proposition Manager UKLB 15 September 2024 3

4. 2 What s new in diagnostic technology? FOCUS - CHD killer questions - Julie Scott Underwriting Proposition Manager UKLB 15 September 2024 4

5. Whats new in diagnostic technology? High tech scanning to predict events? Clinical collaboration - biomarkers for the earliest stages of CHD? On the spot MI diagnosis? Predict risk in healthy lives? Cardiac myosin binding Protein C (cMyC) test Spot stable/unstable plaques via imaging One brave idea US collaboration to look at new ways to analyse data, new diagnostics, new prevention and treatment strategies Scans to determine fat attenuation index or FAI FOCUS - CHD killer questions - Julie Scott Underwriting Proposition Manager UKLB 15 September 2024 5

6. 3 What s the impact of new technology? FOCUS - CHD killer questions - Julie Scott Underwriting Proposition Manager UKLB 15 September 2024 6

7. Whats the impact of new technology? New cardiac Markers? Predicting cardiac events? Biomarkers for the earliest stages of CHD? Predict risk in healthy lives? Earlier diagnosis? Whom will diagnose? More monitoring? How stable is a stable plaque? What preventative measures should be taken? What about lifestyle and environment? More accuracy? Balance of risk v patient intervention and outcome FOCUS - CHD killer questions - Julie Scott Underwriting Proposition Manager UKLB 15 September 2024 7

8. Whats the impact of new technology? More studies needed Medium termClinical utility v Does it give a patient better care/outcome? Behaviour? Short term Longer term cost FOCUS - CHD killer questions - Julie Scott Underwriting Proposition Manager UKLB 15 September 2024 8

9. 4 How could this affect insurance products? FOCUS - CHD killer questions - Julie Scott Underwriting Proposition Manager UKLB 15 September 2024 9

10. How could this affect insurance products? Consumer need? Pricing? Definitions and product development? Application and claims processes? FOCUS - CHD killer questions - Julie Scott Underwriting Proposition Manager UKLB 15 September 2024 10

11. 5 Open the floor for questions FOCUS - CHD killer questions - Julie Scott Underwriting Proposition Manager UKLB 15 September 2024 11

12. 8 Appendix slides FOCUS - CHD killer questions - Julie Scott Underwriting Proposition Manager UKLB 15 September 2024 12

13. Whats new in diagnostic technology? 1. On the spot MI diagnosis? - Cardiac myosin binding Protein C (cMyC) test 2. High tech scanning to predict events? - Spot stable/unstable plaques via imaging 3. Predict risk in healthy lives? - CT scans to determine fat attenuation scores 4. Biomarkers for the earliest stages of CHD? - One brave idea collaboration to look at new ways to analyse data, new diagnostics, new prevention and treatment strategies AHA, Verily and Astra Zeneca in US FOCUS - CHD killer questions - Julie Scott Underwriting Proposition Manager UKLB 15 September 2024 13

14. How could this affect insurance products, especially for underwriting and claims? Consumer need? Pricing? Definitions and product development? Application and claims processes? FOCUS - CHD killer questions - Julie Scott Underwriting Proposition Manager UKLB 15 September 2024 14

15. Open the floor for questions FOCUS - CHD killer questions - Julie Scott Underwriting Proposition Manager UKLB 15 September 2024 15